EcoDrugPlus

Proteasome Subunit Alpha 3

Ensembl ID : ENSMAUG00000020737
Gene Symbol: PSMA3
1 Cross references
220 Possible Orthologues:

Proteasome Subunit Alpha 7

Ensembl ID : ENSMAUG00000011223
Gene Symbol: PSMA7
1 Cross references
151 Possible Orthologues:

Proteasome Subunit Alpha 8

Ensembl ID : ENSMAUG00000017223
Gene Symbol: PSMA8
1 Cross references
197 Possible Orthologues:

Proteasome Subunit Alpha Type-1

Ensembl ID : ENSMAUG00000008437
Gene Symbol: LOC101822549
2 Cross references
263 Possible Orthologues:

Proteasome Subunit Beta 11

Ensembl ID : ENSMAUG00000017123
Gene Symbol: PSMB11
3 Cross references
227 Possible Orthologues:

Protein Kinase C Alpha

Ensembl ID : ENSMAUG00000008808
Gene Symbol: PRKCA
4 Cross references
289 Possible Orthologues:

Protein Kinase C Delta

Ensembl ID : ENSMAUG00000021435
Gene Symbol: PRKCD
3 Cross references
280 Possible Orthologues:

Protein Kinase C Epsilon

Ensembl ID : ENSMAUG00000000294
Gene Symbol: PRKCE
3 Cross references
313 Possible Orthologues:

Protein Kinase C Iota

Ensembl ID : ENSMAUG00000020818
Gene Symbol: PRKCI
4 Cross references
193 Possible Orthologues:

Protein Kinase C Theta

Ensembl ID : ENSMAUG00000019293
Gene Symbol: PRKCQ
4 Cross references
203 Possible Orthologues:

Protein Kinase C Zeta

Ensembl ID : ENSMAUG00000016289
Gene Symbol: PRKCZ
4 Cross references
201 Possible Orthologues:

Protein Kinase C, Beta

Ensembl ID : ENSMAUG00000013071
Gene Symbol: PRKCB
1 Cross references
283 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).